Qube Research & Technologies LTD Takeda Pharmaceutical CO LTD Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Qube Research & Technologies LTD holds 130,117 shares of TAK stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,117

Holding current value

$1.73 Million

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.0 - $15.08 $1.69 Million - $1.96 Million	130,117 New	130,117 $1.85 Million
Q1 2024 May 14, 2024	SELL	$13.89 - $15.04 $4.44 Million - $4.8 Million	-319,309 Reduced 73.66%	114,209 $1.59 Million
Q4 2023 Feb 13, 2024	BUY	$13.36 - $15.43 $1.96 Million - $2.27 Million	146,813 Added 51.21%	433,518 $6.19 Million
Q3 2023 Nov 13, 2023	SELL	$15.03 - $16.32 $6.69 Million - $7.26 Million	-444,953 Reduced 60.81%	286,705 $4.44 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $6.15 Million - $6.75 Million	394,761 Added 117.18%	731,658 $11.5 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $5.15 Million - $5.55 Million	336,897 New	336,897 $5.55 Million
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $2.86 Million - $3.28 Million	-218,322 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$13.54 - $15.35 $214,933 - $243,665	15,874 Added 7.84%	218,322 $3.13 Million
Q4 2021 Feb 01, 2022	BUY	$13.17 - $16.4 $97,036 - $120,835	7,368 Added 3.78%	202,448 $2.76 Million
Q3 2021 Nov 12, 2021	BUY	$16.3 - $17.26 $3.18 Million - $3.37 Million	195,080 New	195,080 $3.2 Million
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $3.12 Million - $3.52 Million	-188,713 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $160,382 - $191,000	-9,598 Reduced 4.84%	188,713 $3.45 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $4.32 Million - $5.32 Million	-280,588 Reduced 58.59%	198,311 $3.61 Million
Q3 2020 Nov 12, 2020	BUY	$17.1 - $19.19 $6.03 Million - $6.76 Million	352,389 Added 278.55%	478,899 $8.54 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $1.85 Million - $2.47 Million	126,510 New	126,510 $2.27 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $1.23 Million - $1.92 Million	-94,412 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $1.09 Million - $1.34 Million	64,525 Added 215.9%	94,412 $1.86 Million
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $47,044 - $52,404	-2,913 Reduced 8.88%	29,887 $514,000
Q2 2019 Aug 02, 2019	BUY	$16.58 - $20.49 $543,824 - $672,072	32,800 New	32,800 $581,000
Q1 2019 May 15, 2019	SELL	$16.7 - $21.52 $1.16 Million - $1.49 Million	-69,304 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $1.08 Million - $1.46 Million	69,304 New	69,304 $1.17 Million

Others Institutions Holding TAK

# of Institutions

336

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Takeda Pharmaceutical CO LTD Transaction History